NO883468L - Fremgangsmaate til fremstilling av farmasoeytiske blandinger inneholdende cyklopeptider som reserpsjonsbefordrere vedapplikasjon paa slimhuden. - Google Patents

Fremgangsmaate til fremstilling av farmasoeytiske blandinger inneholdende cyklopeptider som reserpsjonsbefordrere vedapplikasjon paa slimhuden.

Info

Publication number
NO883468L
NO883468L NO88883468A NO883468A NO883468L NO 883468 L NO883468 L NO 883468L NO 88883468 A NO88883468 A NO 88883468A NO 883468 A NO883468 A NO 883468A NO 883468 L NO883468 L NO 883468L
Authority
NO
Norway
Prior art keywords
peptides
denotes
amino acid
cyclope
slim
Prior art date
Application number
NO88883468A
Other languages
English (en)
Other versions
NO883468D0 (no
NO179094C (no
NO179094B (no
Inventor
Juergen Kurt Sandow
Rainer Schmiedel
Klaus Wirth
Hans Peter Merkle
Susanne Raechs
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO883468D0 publication Critical patent/NO883468D0/no
Publication of NO883468L publication Critical patent/NO883468L/no
Publication of NO179094B publication Critical patent/NO179094B/no
Publication of NO179094C publication Critical patent/NO179094C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Compounds Of Unknown Constitution (AREA)
NO883468A 1987-08-07 1988-08-04 Fremgangsmåte for fremstilling av et farmasöytisk preparat for påföring på slimhinnen NO179094C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873726324 DE3726324A1 (de) 1987-08-07 1987-08-07 Cyclopeptide als resorptionsfoerderer bei applikation auf die schleimhaeute

Publications (4)

Publication Number Publication Date
NO883468D0 NO883468D0 (no) 1988-08-04
NO883468L true NO883468L (no) 1989-02-08
NO179094B NO179094B (no) 1996-04-29
NO179094C NO179094C (no) 1996-08-07

Family

ID=6333298

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883468A NO179094C (no) 1987-08-07 1988-08-04 Fremgangsmåte for fremstilling av et farmasöytisk preparat for påföring på slimhinnen

Country Status (19)

Country Link
US (1) US5091365A (no)
EP (1) EP0302466B1 (no)
JP (1) JP2764930B2 (no)
KR (1) KR970004039B1 (no)
AT (1) ATE69556T1 (no)
AU (1) AU608878B2 (no)
CA (1) CA1331131C (no)
DE (2) DE3726324A1 (no)
DK (1) DK168273B1 (no)
ES (1) ES2038725T3 (no)
FI (1) FI883643A (no)
GR (1) GR3003733T3 (no)
HU (1) HU199301B (no)
IE (1) IE60871B1 (no)
IL (1) IL87362A0 (no)
NO (1) NO179094C (no)
NZ (1) NZ225715A (no)
PT (1) PT88192B (no)
ZA (1) ZA885724B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW274552B (no) * 1992-05-26 1996-04-21 Hoechst Ag
WO1995001368A1 (en) * 1993-06-29 1995-01-12 Ferring B.V. Improved synthesis of cyclic peptides
US5767068A (en) * 1997-02-13 1998-06-16 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
IT1294191B1 (it) * 1997-09-05 1999-03-22 Alfa Wassermann Spa Composizioni farmaceutiche contenenti calcitonina in un dosatore spray per somministrazione intranasale.
KR100611559B1 (ko) * 1998-05-08 2007-04-25 동아제약주식회사 칼시토닌을 함유한 비강투여용 약제학적 조성물
SE514606C2 (sv) * 1998-08-26 2001-03-19 Laekartjaenster I Vaestsverige Läkemedel innehållande GnRH-analoger för behandling av schizofreni
DE10014007A1 (de) * 2000-03-22 2001-10-11 Strathmann Ag & Co Neue Darreichungsformen für DSIP
US20020141970A1 (en) * 2001-03-05 2002-10-03 Pettit Dean K. Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
WO2004084859A2 (en) * 2003-03-21 2004-10-07 Nastech Pharmaceutical Company Inc. Nasal calcitonin formulations containing chlorobutanol
MX2018012716A (es) 2016-04-19 2019-02-11 Griffon Pharmaceuticals Inc Peptidos bioactivos pegilados y usos de los mismos.
JP6975437B2 (ja) * 2019-03-25 2021-12-01 国立大学法人 筑波大学 細胞層透過促進剤、薬剤吸収補助用組成物、及び医薬組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0037943B1 (en) * 1980-03-31 1985-08-14 Teijin Limited Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom
US4900730A (en) * 1981-01-14 1990-02-13 Toyo Jozo Co., Ltd. Preparation which promotes the absorption of peptides
JPS58140026A (ja) * 1982-01-14 1983-08-19 Toyo Jozo Co Ltd 吸収性良好な製剤
FR2509175B1 (fr) * 1981-03-06 1987-01-16 Toyo Jozo Kk Preparation therapeutique ayant d'excellentes proprietes d'absorption
US4568665A (en) * 1982-06-25 1986-02-04 Mitchell David C Protein compounds
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
CA1249968A (en) * 1984-04-05 1989-02-14 Kazuo Kigasawa Ointment base
US4537772A (en) * 1984-05-02 1985-08-27 Merck & Co., Inc. Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines
JPS6160620A (ja) * 1984-09-03 1986-03-28 Teijin Ltd ピログルタミン酸エステル類を含有する医薬品組成物
DE3532074A1 (de) * 1985-09-09 1987-03-12 Berlin Chemie Veb Resorptionsvermittler fuer biologisch aktive peptide

Also Published As

Publication number Publication date
EP0302466B1 (de) 1991-11-21
IL87362A0 (en) 1989-01-31
PT88192B (pt) 1995-03-01
KR970004039B1 (ko) 1997-03-24
GR3003733T3 (no) 1993-03-16
DK168273B1 (da) 1994-03-07
NO883468D0 (no) 1988-08-04
ATE69556T1 (de) 1991-12-15
ES2038725T3 (es) 1993-08-01
FI883643A0 (fi) 1988-08-04
DE3726324A1 (de) 1989-02-16
IE882408L (en) 1989-02-07
DK440888A (da) 1989-02-08
ZA885724B (en) 1989-04-26
AU2043388A (en) 1989-04-20
NZ225715A (en) 1991-02-26
KR890003409A (ko) 1989-04-14
US5091365A (en) 1992-02-25
NO179094C (no) 1996-08-07
DK440888D0 (da) 1988-08-05
CA1331131C (en) 1994-08-02
NO179094B (no) 1996-04-29
DE3866307D1 (de) 1992-01-02
EP0302466A1 (de) 1989-02-08
IE60871B1 (en) 1994-08-24
PT88192A (pt) 1989-06-30
HU199301B (en) 1990-02-28
FI883643A (fi) 1989-02-08
AU608878B2 (en) 1991-04-18
JPS6466128A (en) 1989-03-13
HUT47599A (en) 1989-03-28
JP2764930B2 (ja) 1998-06-11

Similar Documents

Publication Publication Date Title
NO883073L (no) 3-desmetyl-mevalonsyrederivater, fremgangsmaate for fremstilling av dem, farmasoeytiske preparater paa basis av disse forbindelsene, deres anvendelse saavel som mellomprodukter.
NO882732D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
EE04800B1 (et) Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks
NO903911D0 (no) Fremgangsmaate for fremstilling av 4-hydroksytetrahydropyran-2-on og de tilsvarende dihydroksykarboksylsyrederivater, salter og estere, deres anvendelse som legemidler, farmasoeytiske preparater og forprodukter.
NO883468L (no) Fremgangsmaate til fremstilling av farmasoeytiske blandinger inneholdende cyklopeptider som reserpsjonsbefordrere vedapplikasjon paa slimhuden.
GB2285219A (en) Use of norastemizole for the treatment of allergic disorders
NO870049D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO172537C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-desmetyl-4-fluor-mevalonsyrederivater
DK408083A (da) Isoquinolinderivater, deres fremstilling og anvendelse
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
ES2044170T3 (es) Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen.
ES2054089T3 (es) Formulaciones orales liquidas.
BR9712033A (pt) Composição farmacêutica para tratamento de doenças virais.
DK279988A (da) Spiro(4,5)decanderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
NO913644D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
PT82847B (pt) Processo para a preparacao de composicoes farmaceuticas contendo 4-amino-2-(imidazolodina-2-ona-1-il)-pirimidina-5-carboxil-(n-(3-trifluormetil-fenil)-amidas)
SE8402199L (sv) Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist
ATE12649T1 (de) Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.
NO873385D0 (no) Oksiran-pseudooligosakkarider, fremgangsmaate til deres fremstilling, deres anvendelse og farmasoeytiske preparater.
SE8603517D0 (sv) Heterocyclic compounds and their preparation and pharmaceutical formulation
NO823682L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridazinonimin-derivater.
NO851145L (no) N-bicykloheptyl- og n-bicykloheptenyl-imidazoler, fremgangsmaate til deres fremstilling, deres anvendelse samt farmasoeytiske preparater
IT1259140B (it) Formulazioni farmaceutiche per la somministraziane orale di calcitonina
IT1262567B (it) Pirrolidin-2-oni,loro preparazione,composizioni farmaceutiche che li contengono e loro uso in terapia.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN FEBRUARY 2002